Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anikó Lovik

Showing results (1-10 of 32) with videos related to

Pageof 4
Sort By:
Behavior Research Methods|February 2, 2018
On using multiple imputation for exploratory factor analysis of incomplete dataVahid Nassiri, Anikó Lovik, Geert Molenberghs, et al.
Behavior Research Methods|February 3, 2018
On using multiple imputation for exploratory factor analysis of incomplete dataVahid Nassiri, Anikó Lovik, Geert Molenberghs, et al.
The Journal of Rheumatology|January 16, 2022
Evaluation of Disease Burden by (Separate) Patient-reported, Clinical, and Laboratory Factor Scores in Patients With Established Rheumatoid Arthritis: A Factor Analysis ReplicationSofia Pazmino, Anikó Lovik, René Westhovens, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|January 31, 2026
Methodological considerations in the analysis of survival data in amyotrophic lateral sclerosisSolmaz Yazdani, Christina Seitz, John Andersson, et al.
Clinical Immunology (Orlando, Fla.)|June 9, 2024
T cell subset composition differs between blood and cerebrospinal fluid in amyotrophic lateral sclerosisSolmaz Yazdani, Anikó Lovik, Christina Seitz, et al.
JAMA Network Open|June 4, 2025
Use of Common Psychiatric Medications and Risk and Prognosis of Amyotrophic Lateral SclerosisCharilaos Chourpiliadis, Anikó Lovik, Caroline Ingre, et al.
Brain and Behavior|May 19, 2025
Venous Bicarbonate as a Prognostic Biomarker and Proposed Proxy for Vital Capacity to Be Used as an Eligibility Criterion in Amyotrophic Lateral Sclerosis Clinical TrialsJuliette Foucher, Therese Wellander, Anikó Lovik, et al.
Journal of Neurology|December 12, 2024
Exploring clinical chemistry markers in amyotrophic lateral sclerosis: insights into survival and disease trajectoriesIoannis Psychogios, Yihan Hu, Christina Seitz, et al.
Journal of Neurology|January 8, 2025
Correction: Repeated cognitive assessments show stable function over time in patients with ALSLinn Öijerstedt, Juliette Foucher, Anikó Lovik, et al.
Journal of Neurology|June 9, 2024
Repeated cognitive assessments show stable function over time in patients with ALSLinn Öijerstedt, Juliette Foucher, Anikó Lovik, et al.
Pageof 4

Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
Behavior Research Methods|February 2, 2018
On using multiple imputation for exploratory factor analysis of incomplete dataVahid Nassiri, Anikó Lovik, Geert Molenberghs, et al.
Behavior Research Methods|February 3, 2018
On using multiple imputation for exploratory factor analysis of incomplete dataVahid Nassiri, Anikó Lovik, Geert Molenberghs, et al.
The Journal of Rheumatology|January 16, 2022
Evaluation of Disease Burden by (Separate) Patient-reported, Clinical, and Laboratory Factor Scores in Patients With Established Rheumatoid Arthritis: A Factor Analysis ReplicationSofia Pazmino, Anikó Lovik, René Westhovens, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|January 31, 2026
Methodological considerations in the analysis of survival data in amyotrophic lateral sclerosisSolmaz Yazdani, Christina Seitz, John Andersson, et al.
Clinical Immunology (Orlando, Fla.)|June 9, 2024
T cell subset composition differs between blood and cerebrospinal fluid in amyotrophic lateral sclerosisSolmaz Yazdani, Anikó Lovik, Christina Seitz, et al.
JAMA Network Open|June 4, 2025
Use of Common Psychiatric Medications and Risk and Prognosis of Amyotrophic Lateral SclerosisCharilaos Chourpiliadis, Anikó Lovik, Caroline Ingre, et al.
Brain and Behavior|May 19, 2025
Venous Bicarbonate as a Prognostic Biomarker and Proposed Proxy for Vital Capacity to Be Used as an Eligibility Criterion in Amyotrophic Lateral Sclerosis Clinical TrialsJuliette Foucher, Therese Wellander, Anikó Lovik, et al.
Journal of Neurology|December 12, 2024
Exploring clinical chemistry markers in amyotrophic lateral sclerosis: insights into survival and disease trajectoriesIoannis Psychogios, Yihan Hu, Christina Seitz, et al.
Journal of Neurology|January 8, 2025
Correction: Repeated cognitive assessments show stable function over time in patients with ALSLinn Öijerstedt, Juliette Foucher, Anikó Lovik, et al.
Journal of Neurology|June 9, 2024
Repeated cognitive assessments show stable function over time in patients with ALSLinn Öijerstedt, Juliette Foucher, Anikó Lovik, et al.
Pageof 4